Aurora Biosciences acquired PanVera Corporation in an all-stock deal valued at ~$86M to add protein-production and high-throughput screening assay capabilities to its drug-discovery platform; Aurora (with PanVera embedded) was itself acquired by Vertex Pharmaceuticals in 2001 for ~$592M.